Flora Growth Corp. Files DEF 14A
Ticker: ZSTK · Form: DEF 14A · Filed: Jun 28, 2024 · CIK: 1790169
| Field | Detail |
|---|---|
| Company | Flora Growth Corp. (ZSTK) |
| Form Type | DEF 14A |
| Filed Date | Jun 28, 2024 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance, shareholder-meeting
Related Tickers: FLGC
TL;DR
Flora Growth Corp. filed their DEF 14A, shareholders need to review governance and executive details.
AI Summary
Flora Growth Corp. filed a DEF 14A on June 28, 2024, for the period ending August 14, 2024. The filing details various corporate actions and disclosures. Key dates mentioned include December 23, 2022, and February 24, 2022, related to franchise and supplier agreements.
Why It Matters
This filing provides crucial information for shareholders and potential investors regarding the company's governance, executive compensation, and significant corporate events.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the specific details within can reveal significant corporate actions or changes that may impact the company's stock.
Key Numbers
- 2022-12-23 — Key Date (Date related to franchise and supplier agreements.)
- 2022-02-24 — Key Date (Date related to Just Brands LLC and High Roller Private Label LLC agreements.)
Key Players & Entities
- Flora Growth Corp. (company) — Filer
- 0001062993-24-013130 (filing_id) — Accession Number
- 20240628 (date) — Filing Date
- 20240814 (date) — Period of Report
- FranchiseGlobalHealthIncMember (company_related_entity) — Related Entity
- JustBrandsLlcAndHighRollerPrivateLabelLlcMember (company_related_entity) — Related Entity
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to solicit proxies from shareholders for an upcoming annual or special meeting.
When was this specific DEF 14A filing by Flora Growth Corp. submitted?
Flora Growth Corp.'s DEF 14A filing was submitted on June 28, 2024.
What is the period of report for this filing?
The period of report for this DEF 14A filing is up to August 14, 2024.
Are there any specific agreements mentioned with dates in the provided text?
Yes, the filing mentions dates such as December 23, 2022, and February 24, 2022, in relation to entities like FranchiseGlobalHealthIncMember and JustBrandsLlcAndHighRollerPrivateLabelLlcMember.
What is the standard industrial classification for Flora Growth Corp.?
Flora Growth Corp. is classified under 'PHARMACEUTICAL PREPARATIONS' with the SIC code 2834.
Filing Stats: 4,786 words · 19 min read · ~16 pages · Grade level 14.1 · Accepted 2024-06-28 16:02:37
Filing Documents
- formdef14a.htm (DEF 14A) — 5857KB
- formdef14axz001.jpg (GRAPHIC) — 11KB
- formdef14axz002.jpg (GRAPHIC) — 11KB
- formdef14axz003.jpg (GRAPHIC) — 11KB
- formdef14axz004.jpg (GRAPHIC) — 159KB
- formdef14axz005.jpg (GRAPHIC) — 166KB
- formdef14axz006.jpg (GRAPHIC) — 12KB
- 0001062993-24-013130.txt ( ) — 23777KB
- flgc-20240331.xsd (EX-101.SCH) — 154KB
- flgc-20240331_cal.xml (EX-101.CAL) — 78KB
- flgc-20240331_def.xml (EX-101.DEF) — 714KB
- flgc-20240331_lab.xml (EX-101.LAB) — 1515KB
- flgc-20240331_pre.xml (EX-101.PRE) — 832KB
- formdef14a_htm.xml (XML) — 4778KB
Executive Compensation
Executive Compensation 31
Financial Statements
Financial Statements 47 Proposal No. 1 - Election of Directors * 47 Proposal No. 2 - Re-appointment of Independent Registered Public Accounting * 48 Proposal No. 3 - Approval of the 2022 Plan Amendment Proposal * 50 Proposal No. 4 - Approval of the Stock Appreciation Rights Proposal * 67 Proposal No. 5 - Approval of the Share Issuance Proposal * 72 Audit Committee Report 121 Where to Get Additional Information 123 Cost of Proxy Statement 123 Shareholder Communications 123 Other Business * 124 * To be voted on at the meeting SUMMARY TERM SHEET This summary term sheet summarizes certain information contained in this proxy statement (this "Proxy Statement") but may not contain all of the information that is important to you. You should read carefully this entire Proxy Statement, including the attached Annexes, for a more complete understanding of the matters to be considered at the 2024 Annual and Special Meeting of Shareholders (including any adjournments of or postponements thereof, the "Annual Meeting"). On April 1, 2024, Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the "Company" or "Flora") entered into a binding letter of intent to acquire all of the issued and outstanding shares of TruHC Pharma GmbH ("TruHC") from TruHC Holding GmbH ("TruHC Holding") in an all-stock deal (the "Acquisition") in exchange for 2,770,562 common shares, no par value, of the Company (the "Common Shares"). On April 16, 2024, the Company entered into a stock purchase agreement (the "Stock Purchase Agreement") with TruHC Holding. The Stock Purchase Agreement provides for the acquisition of 100% of the issued and outstanding shares of TruHC, of which 100% was owned by TruHC Holding. On April 22, 2024, the Company completed the first closing (the "First Closing") in exchange for a total of 2,135,199 Common Shares, representing approximately 77% of TruHC. The second closing (the "Second Closing") for the balance